由ACKR2缺乏NK细胞增强的CCR2表达增加了瘤杀伤细胞治疗的疗效
Alan J Hayes1, Marieke Pingen1, Gillian Wilson1
1Chemokine Research Group, School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Sir Graeme Davis Building, 120 University Place, Glasgow G12 8TA, United Kingdom.
Journal of leukocyte biology
|July 25, 2024
概括
在小鼠中非典型的化学因受体2 (ACKR2) 缺陷不会直接抑制转移. 增强的自然杀手细胞归因于突变,这表明CCR2+自然杀手细胞可以改善抗转移疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞疗法细胞疗法
背景情况:
- 化基因引导白细胞到特定的部位,影响细胞治疗的指导.
- 非典型的化学因受体2 (ACKR2) 缺乏的小鼠显示转移率降低,与增强的自然杀手 (NK) 细胞同源相关.
- 在ACKR2-/-小鼠中增强的NK细胞定位以前归因于增加的CCR2表达.
研究的目的:
- 调查ACKR2在转移抑制中的直接作用.
- 为了确定ACKR2-/-小鼠NK细胞上增强的CCR2表达的原因.
- 评估CCR2+NK细胞在抗转移策略中的治疗潜力.
主要方法:
- 使用了ACKR2-缺陷 (ACKR2-/-) 的小鼠模型.
- 分析了NK细胞种群和CCR2表达.
- 研究了增强NK细胞CCR2表达的遗传起源.
- 评估了精选的CCR2+NK细胞的抗转移能力.
主要成果:
- 在ACKR2-/-小鼠中的转移抑制表型不是ACKR2缺失的直接影响.
- 增强的NK细胞CCR2表达源于ACKR2-/-小鼠菌株生成过程中的乘客突变.
- 选择CCR2+NK细胞丰富了具有优越抗转移能力的种群.
- 瘤通常表达CCR2连接体,表明可向的途径.
结论:
- 缺乏ACKR2并没有直接赋予抗转移性质.
- 乘客突变,而不是ACKR2缺席,驱动增强NK细胞CCR2表达和抗转移功能.
- CCR2+NK细胞具有显著的抗转移潜力.
- 向CCR2+NK细胞是基于细胞的瘤杀伤疗法的有希望的策略.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
883
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
883
Cells of the Innate Immune Response
1.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


